Company Name: Zynerba Pharmaceuticals, Inc.    

Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The company is engaged in the development of proprietary synthetic cannabinoid therapeutics designed for transdermal delivery.  The company’s developmental pipeline includes:

  • CBD Gel: Product candidate for Fragile X syndrome, osteoarthritis and refractory epilepsy
  • THC Pro-Drug Patch: Product candidate for fibromyalgia and peripheral neuropathic pain

Ticker Symbol: ZYNE (NASDAQ)

Company Website: http://zynerba.com

Social Media:

Zynerba Pharmaceuticals LinkedIn

Zynerba Pharmaceuticals Twitter

Headquarters: Devon, PA